We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Hemoglobin Assay Performed with Photothermal Optical Sensor

By LabMedica International staff writers
Posted on 11 Jan 2015
An optical sensor, termed a photothermal spectral-domain optical coherence reflectometer (PT SD-OCR) is capable of direct measurement of hemoglobin concentration (Hb) without chemicals and preprocessing of blood.

The PT SD-OCR OCR measures Hb by quantifying refractive index changes of blood samples due to photothermal effect under the irradiation of 532-nm light and its diagnostic accuracy and precision has been evaluated in anemic patients.

Scientists at the Yonsei University (Seoul, Republic of Korea) and their colleagues used PT SD-OCR to measure Hb in 50 anemic patients, and examined its accuracy against a hematology analyzer. More...
Its precision was assessed by examining the standard deviation (SD) and coefficients of variation (CV) based on 20 repeated measurements on three blood sample and its performance was also compared with a hemoglobinometer.

The relative accuracy of the PT SD-OCR sensor was examined and the comparisons of the PT SD-OCR and HemoCue 201+ System (Angelholm, Sweden) against the results from the ADVIA 2120i hematology analyze (Siemens AG, Erlangen, Germany). An excellent correlation was observed between the results from the hematology analyzer and those of the PT SD-OCR sensor. The precision of the PT SD-OCR sensor was also comparable with the ADVIA 2120i analyzer and the HemoCue 201+ detector.

The authors concluded that simple and chemical-free operation of PT SD-OCR enabled rapid and accurate measurement of Hb in anemic patients. The sensor is expected to facilitate clinical procedures related to blood-related disorders in patient care. The PT SD-OCR sensor may therefore be readily utilized in clinical settings for hemoglobin detection and determination of proper treatment strategies for anemic patients. The study was published in the January 2015 issue of the journal Clinica Chimica Acta.

Related Links:

Yonsei University
HemoCue
Siemens AG 



Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated MALDI-TOF MS System
EXS 3000
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The Elecsys pTau-181 test helps rule out Alzheimer’s disease in symptomatic patients aged 55 and older by identifying absence of amyloid pathology (photo courtesy of Roche)

Simple Blood Test Offers New Path to Alzheimer’s Assessment in Primary Care

Timely evaluation of cognitive symptoms in primary care is often limited by restricted access to specialized diagnostics and invasive confirmatory procedures. Clinicians need accessible tools to determine... Read more

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Pathology

view channel
Image: The innovative classifier can guide treatment for PDAC and other immunotherapy-resistant cancers (Photo courtesy of Adobe Stock))

Single Sample Classifier Predicts Cancer-Associated Fibroblast Subtypes in Patient Samples

Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers, in part because of its dense tumor microenvironment that influences how tumors grow and respond to treatment.... Read more

Industry

view channel
Image: QuidelOrtho has entered into a strategic supply agreement with Lifotronic to expand its global immunoassay portfolio (Photo courtesy of QuidelOrtho)

QuidelOrtho Collaborates with Lifotronic to Expand Global Immunoassay Portfolio

QuidelOrtho (San Diego, CA, USA) has entered a long-term strategic supply agreement with Lifotronic Technology (Shenzhen, China) to expand its global immunoassay portfolio and accelerate customer access... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.